NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EpiBone

EpiBone

Private
Jersey City, New JerseyHealthcare & Life Scienceshttps://www.epibone.com/

Last Round

Convertible Debt

Nov 8, 2024

Total Funding Raised

$60.71M

Company Overview

EpiBone is a biotechnology company that develops personalized, living bone and cartilage grafts using a patient's own stem cells and 3D-printed scaffolds for skeletal reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinebone graftcartilage regenerationtissue engineeringpersonalized medicinestem cell therapybioreactorskeletal reconstructionlab-grown tissuebiotechorthopedic surgerycraniofacial reconstructionbiomaterialsclinical trialsbiofabrication

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiBone Comparables

Compare EpiBone with similar companies based on industry and business-model similarity.

EpiBone comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

EpiBone Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtNov 8, 2024
GrantAug 16, 2024
Series BSep 20, 2023
Series BDec 27, 2022
Series B ExtensionNov 26, 2021
Debt
Feb 12, 2021

Key People

Founding team and executive leadership

PhD/MBA Nina Tandon

CEO, Co-founder

Founding Team

EpiBone Investors

Notable investors and investment history

EpiBone investors
InvestorRounds
Kendall Capital PartnersConvertible Debt, Series B
United States Department of DefenseGrant
Thiel FoundationVC Round, Grant, Seed
Plum Alley InvestmentsVC Round
Tech Council VenturesVC Round
Breakout VenturesVC Round, Grant
Alexandria Venture InvestmentsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2024

    $75K grant from the United States Department of Defense.

  • Dec 8, 2014

    $250K round with EMV Capital and Thiel Foundation

EpiBone Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EpiBone Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EpiBone's valuation, stock price, and market status.

Firmographic Details

HeadquartersJersey City, New Jersey
Employee Range21
Year Founded2013
Last FundingNov 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.